An integrated multiple-analyte pharmacokinetic model to characterize trastuzumab emtansine (T-DM1) clearance pathways and to evaluate reduced pharmacokinetic sampling in patients with HER2-positive metastatic breast cancer. (Q54439772)
Jump to navigation
Jump to search
scientific article published in August 2013
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | An integrated multiple-analyte pharmacokinetic model to characterize trastuzumab emtansine (T-DM1) clearance pathways and to evaluate reduced pharmacokinetic sampling in patients with HER2-positive metastatic breast cancer. |
scientific article published in August 2013 |
Statements
An integrated multiple-analyte pharmacokinetic model to characterize trastuzumab emtansine (T-DM1) clearance pathways and to evaluate reduced pharmacokinetic sampling in patients with HER2-positive metastatic breast cancer. (English)
1 reference
Dan Lu
1 reference
Amita Joshi
1 reference
Bei Wang
1 reference
Steve Olsen
1 reference
Joo-Hee Yi
1 reference
Ian E Krop
1 reference
Howard A Burris
1 reference
Sandhya Girish
1 reference
1 August 2013
1 reference
52
1 reference
8
1 reference
657-672
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference